Literature DB >> 18056687

Robust combination of multiple diagnostic tests for classifying censored event times.

T Cai1, S Cheng.   

Abstract

Recent advancement in technology promises to yield a multitude of tests for disease diagnosis and prognosis. When there are multiple sources of information available, it is often of interest to construct a composite score that can provide better classification accuracy than any individual measurement. In this paper, we consider robust procedures for optimally combining tests when test results are measured prior to disease onset and disease status evolves over time. To account for censoring of disease onset time, the most commonly used approach to combining tests to detect subsequent disease status is to fit a proportional hazards model (Cox, 1972) and use the estimated risk score. However, simulation studies suggested that such a risk score may have poor accuracy when the proportional hazards assumption fails. We propose the use of a nonparametric transformation model (Han, 1987) as a working model to derive an optimal composite score with theoretical justification. We demonstrate that the proposed score is the optimal score when the model holds and is optimal "on average" among linear scores even if the model fails. Time-dependent sensitivity, specificity, and receiver operating characteristic curve functions are used to quantify the accuracy of the resulting composite score. We provide consistent and asymptotically Gaussian estimators of these accuracy measures. A simple model-free resampling procedure is proposed to obtain all consistent variance estimators. We illustrate the new proposals with simulation studies and an analysis of a breast cancer gene expression data set.

Entities:  

Mesh:

Year:  2007        PMID: 18056687     DOI: 10.1093/biostatistics/kxm037

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  13 in total

1.  AUC-based biomarker ensemble with an application on gene scores predicting low bone mineral density.

Authors:  X G Zhao; W Dai; Y Li; L Tian
Journal:  Bioinformatics       Date:  2011-09-09       Impact factor: 6.937

2.  Study design in high-dimensional classification analysis.

Authors:  Brisa N Sánchez; Meihua Wu; Peter X K Song; Wen Wang
Journal:  Biostatistics       Date:  2016-05-05       Impact factor: 5.899

3.  Developing and evaluating risk prediction models with panel current status data.

Authors:  Stephanie Chan; Xuan Wang; Ina Jazić; Sarah Peskoe; Yingye Zheng; Tianxi Cai
Journal:  Biometrics       Date:  2020-06-19       Impact factor: 2.571

4.  Augmented estimation for t-year survival with censored regression models.

Authors:  Yu Zheng; Tianxi Cai
Journal:  Biometrics       Date:  2017-03-10       Impact factor: 2.571

5.  Development and evaluation of multi-marker risk scores for clinical prognosis.

Authors:  Benjamin French; Paramita Saha-Chaudhuri; Bonnie Ky; Thomas P Cappola; Patrick J Heagerty
Journal:  Stat Methods Med Res       Date:  2012-07-05       Impact factor: 3.021

6.  A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data.

Authors:  Hajime Uno; Lu Tian; Tianxi Cai; Isaac S Kohane; L J Wei
Journal:  Stat Med       Date:  2012-10-05       Impact factor: 2.373

7.  Landmark risk prediction of residual life for breast cancer survival.

Authors:  Layla Parast; Tianxi Cai
Journal:  Stat Med       Date:  2013-03-14       Impact factor: 2.373

8.  Nonparametric receiver operating characteristic-based evaluation for survival outcomes.

Authors:  Xiao Song; Xiao-Hua Zhou; Shuangge Ma
Journal:  Stat Med       Date:  2012-10-15       Impact factor: 2.373

9.  Robust risk prediction with biomarkers under two-phase stratified cohort design.

Authors:  Rebecca Payne; Ming Yang; Yingye Zheng; Majken K Jensen; Tianxi Cai
Journal:  Biometrics       Date:  2016-04-01       Impact factor: 2.571

10.  Subgroup specific incremental value of new markers for risk prediction.

Authors:  Qian M Zhou; Yingye Zheng; Tianxi Cai
Journal:  Lifetime Data Anal       Date:  2012-12-23       Impact factor: 1.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.